학술논문
Safety of the novel oral poliovirus vaccine type 2 (nOPV2) in infants and young children aged 1 to <5 years and lot-to-lot consistency of the immune response to nOPV2 in infants in The Gambia: a phase 3, double-blind, randomised controlled trial
Document Type
Article
Author
Source
In: The Lancet . (The Lancet, 23 March 2024, 403(10432):1164-1175)
Subject
Language
English
ISSN
1474547X
01406736
01406736